vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Hasbro (HAS). Click either name above to swap in a different company.

Hasbro is the larger business by last-quarter revenue ($1.4B vs $749.2M, roughly 1.9× CLOVER HEALTH INVESTMENTS, CORP.). Hasbro runs the higher net margin — 13.9% vs 3.6%, a 10.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 31.3%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 38.2%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Hasbro, Inc. is an American multinational toy manufacturing and entertainment holding company founded on December 6, 1923 by Henry, Hillel and Herman Hassenfeld and is incorporated and headquartered in Pawtucket, Rhode Island. Hasbro owns the trademarks and products of Kenner, Milton Bradley, Parker Brothers, and Wizards of the Coast, among others. As of August 2020, over 81.5% of its shares were held by large financial institutions.

CLOV vs HAS — Head-to-Head

Bigger by revenue
HAS
HAS
1.9× larger
HAS
$1.4B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+30.8% gap
CLOV
62.0%
31.3%
HAS
Higher net margin
HAS
HAS
10.3% more per $
HAS
13.9%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
38.2%
HAS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
HAS
HAS
Revenue
$749.2M
$1.4B
Net Profit
$27.3M
$201.6M
Gross Margin
68.7%
Operating Margin
3.6%
20.6%
Net Margin
3.6%
13.9%
Revenue YoY
62.0%
31.3%
Net Profit YoY
687.8%
EPS (diluted)
$0.05
$1.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
HAS
HAS
Q1 26
$749.2M
Q4 25
$487.7M
$1.4B
Q3 25
$496.6M
$1.4B
Q2 25
$477.6M
$980.8M
Q1 25
$462.3M
$887.1M
Q4 24
$337.0M
$1.1B
Q3 24
$331.0M
$1.3B
Q2 24
$356.3M
$995.3M
Net Profit
CLOV
CLOV
HAS
HAS
Q1 26
$27.3M
Q4 25
$-49.3M
$201.6M
Q3 25
$-24.4M
$233.2M
Q2 25
$-10.6M
$-855.8M
Q1 25
$-1.3M
$98.6M
Q4 24
$-22.1M
$-34.3M
Q3 24
$-9.2M
$223.2M
Q2 24
$7.4M
$138.5M
Gross Margin
CLOV
CLOV
HAS
HAS
Q1 26
Q4 25
68.7%
Q3 25
70.1%
Q2 25
77.0%
Q1 25
76.9%
Q4 24
67.4%
Q3 24
24.5%
70.4%
Q2 24
30.3%
76.1%
Operating Margin
CLOV
CLOV
HAS
HAS
Q1 26
3.6%
Q4 25
-10.1%
20.6%
Q3 25
-4.9%
24.6%
Q2 25
-2.2%
-81.4%
Q1 25
-0.3%
19.2%
Q4 24
-6.4%
5.4%
Q3 24
-2.7%
23.6%
Q2 24
2.0%
21.3%
Net Margin
CLOV
CLOV
HAS
HAS
Q1 26
3.6%
Q4 25
-10.1%
13.9%
Q3 25
-4.9%
16.8%
Q2 25
-2.2%
-87.3%
Q1 25
-0.3%
11.1%
Q4 24
-6.6%
-3.1%
Q3 24
-2.8%
17.4%
Q2 24
2.1%
13.9%
EPS (diluted)
CLOV
CLOV
HAS
HAS
Q1 26
$0.05
Q4 25
$1.46
Q3 25
$1.64
Q2 25
$-6.10
Q1 25
$0.70
Q4 24
$-0.25
Q3 24
$1.59
Q2 24
$0.99

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
HAS
HAS
Cash + ST InvestmentsLiquidity on hand
$177.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
$565.5M
Total Assets
$697.7M
$5.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
HAS
HAS
Q1 26
$177.6M
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Stockholders' Equity
CLOV
CLOV
HAS
HAS
Q1 26
$339.4M
Q4 25
$308.7M
$565.5M
Q3 25
$340.9M
$433.8M
Q2 25
$344.2M
$269.7M
Q1 25
$336.1M
$1.2B
Q4 24
$341.1M
$1.2B
Q3 24
$342.2M
$1.3B
Q2 24
$324.9M
$1.2B
Total Assets
CLOV
CLOV
HAS
HAS
Q1 26
$697.7M
Q4 25
$541.0M
$5.6B
Q3 25
$559.7M
$5.5B
Q2 25
$575.0M
$5.2B
Q1 25
$583.7M
$6.0B
Q4 24
$580.7M
$6.3B
Q3 24
$653.0M
$7.2B
Q2 24
$674.2M
$6.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
HAS
HAS
Operating Cash FlowLast quarter
$403.2M
Free Cash FlowOCF − Capex
$389.5M
FCF MarginFCF / Revenue
26.9%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
2.00×
TTM Free Cash FlowTrailing 4 quarters
$829.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
HAS
HAS
Q1 26
Q4 25
$-66.9M
$403.2M
Q3 25
$12.1M
$280.6M
Q2 25
$5.4M
$71.3M
Q1 25
$-16.3M
$138.1M
Q4 24
$34.8M
$259.8M
Q3 24
$50.0M
$222.5M
Q2 24
$44.8M
$187.3M
Free Cash Flow
CLOV
CLOV
HAS
HAS
Q1 26
Q4 25
$-69.0M
$389.5M
Q3 25
$11.4M
$260.9M
Q2 25
$4.8M
$55.2M
Q1 25
$-16.5M
$124.3M
Q4 24
$33.3M
$200.8M
Q3 24
$49.6M
$174.0M
Q2 24
$44.4M
$135.4M
FCF Margin
CLOV
CLOV
HAS
HAS
Q1 26
Q4 25
-14.1%
26.9%
Q3 25
2.3%
18.8%
Q2 25
1.0%
5.6%
Q1 25
-3.6%
14.0%
Q4 24
9.9%
18.2%
Q3 24
15.0%
13.6%
Q2 24
12.5%
13.6%
Capex Intensity
CLOV
CLOV
HAS
HAS
Q1 26
Q4 25
0.4%
0.9%
Q3 25
0.1%
1.4%
Q2 25
0.1%
1.6%
Q1 25
0.0%
1.6%
Q4 24
0.5%
5.4%
Q3 24
0.1%
3.8%
Q2 24
0.1%
5.2%
Cash Conversion
CLOV
CLOV
HAS
HAS
Q1 26
Q4 25
2.00×
Q3 25
1.20×
Q2 25
Q1 25
1.40×
Q4 24
Q3 24
1.00×
Q2 24
6.04×
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

HAS
HAS

Grow Brands$1.1B75%
Optimize Brands$188.7M13%
Digital And Licensing Gaming$135.7M9%
Class Of Principal Product Family Brands$13.1M1%
Filmand TV$2.4M0%

Related Comparisons